According to some investigators, circulating estrogens can stimulate breast cancer cell proliferation, not only through hormone receptors, but also through the HER-2/neu receptor, and so promote carcinogenesis through common means [4,17,18]. Here, ERBB2 is linked to breast carcinoma.